Zymeworks Inc.

ZYMENASDAQ • USD
26.45 USD
↗ 0.21 (0.80%)AT CLOSE (03:59 PM EST)
26.45
↘ 0.01 (0.02%)
POST MARKET (AS OF 04:15 PM EST)
Post Market
AS OF 04:15 PM EST
26.45
↘ 0.01 (0.02%)
🔴Market: CLOSED

ZYME is currently priced at $26.47. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 16, 2026.

Open?$27.47
High?$27.74
Low?$26.35
Prev. Close?$26.24
Volume?969.7K
Avg. Volume?1.4M
VWAP?$26.72
Rel. Volume?0.71x
Bid / Ask
Bid?$26.37 × 300
Ask?$27.50 × 100
Spread?$1.13
Midpoint?$26.94
Valuation & Ratios
Market Cap?1.8B
Shares Out?69.0M
Float?44.6M
Float %?63.3%
P/E Ratio?42.69
P/B Ratio?7.16
EPS?$0.61
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Employees
264
Market Cap
1.8B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2017-04-28
Address
108 PATRIOT DRIVE, SUITE A
MIDDLETOWN, DE 19709
Phone: 302-274-8744
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
8
Momentum?
23
Short Sent.?
35
Piotroski F-Score?4/9Mixed
Altman Z-Score?0.74Distress
Confidence?69%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.25%High
Short Interest?5.9M
Days to Cover?4.3
Free Float44.6M
Avg Daily Volume1.4M
Settlement Date2026-10-30
Financial Health
Current Ratio?3.30Strong
Quick Ratio?3.30Strong
Cash Ratio?0.62Adequate
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
47/100
P/E?
Peers
100
S&P
16
42.7PRICEY▾
P/B?
Peers
100
S&P
26
7.16FAIR▾
P/S?
Peers
100
S&P
17
6.95FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
8
35.5HIGH▾
EV/Sales?
Peers
100
S&P
23
6.57HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
59
16.8%STRONG▾
ROA?
Peers
50
S&P
33
3.7%FAIR▾
Cash Flow & Enterprise
FCF?$-112834000
Enterprise Value?$1.7B
Fundamentals ratios updated end of day